Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine-Reference-Cited by-同舟云学术

Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine

Published:2019-10-21 Issue:2 Volume:18 Page:169-175
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comp Oncol

Author:

Thamm Douglas H.¹²^ORCID,Weishaar Kristen M.²,Charles Joseph B.²,Ehrhart E. J.¹²³

Affiliation:

1. Cell and Molecular Biology Graduate ProgramColorado State University Fort Collins Colorado

2. Flint Animal Cancer Center, College of Veterinary Medicine and BiosciencesColorado State University Fort Collins Colorado

3. Department of Microbiology, Immunology, and PathologyCollege of Veterinary Medicine and Biosciences, Colorado State University Fort Collins Colorado

Funder

American Kennel Club Canine Health Foundation

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12525

Reference25 articles.

1. Mutations in the Juxtamembrane Domain of c-KIT Are Associated with Higher Grade Mast Cell Tumors in Dogs

2. The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell Tumors

3. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit

4. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c- kit in mast cell tumors of dogs

5. The Role of c-KIT in Tumorigenesis: Evaluation in Canine Cutaneous Mast Cell Tumors

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of feline mast cell tumour with intertumoral heterogeneity: Identification of secondary mutations c.998G>C and c.2383G>C in KIT after resistance to toceranib;Veterinary Medicine and Science;2024-08-23

2. Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in canine tumors;Veterinary Pathology;2024-03-27

3. Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors;Veterinary Pathology;2023-06-26

4. Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat;Clinical Case Reports;2023-06

5. Immunohistochemical and Molecular Genetic Analysis of Canine Digital Mast Cell Tumours;Animals;2023-05-19